Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
Khan
Omar A
OA
Tselis
Alexandros
A
Boster
Aaron
A
D002986:Clinical Trials as Topic / Q000379:methods* / Q000592:standards; D003627:Data Interpretation, Statistical; D004305:Dose-Response Relationship, Drug; D023381:Endpoint Determination / Q000379:methods* / Q000592:standards; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007155:Immunologic Factors / Q000008:administration & dosage; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D017063:Outcome Assessment, Health Care / Q000379:methods* / Q000592:standards; D015203:Reproducibility of Results; D018401:Sample Size; D055502:Secondary Prevention
D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors